HomeCompareHYBT vs ORCC

HYBT vs ORCC: Dividend Comparison 2026

HYBT yields 571.43% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HYBT wins by $175063.44M in total portfolio value
10 years
HYBT
HYBT
● Live price
571.43%
Share price
$0.35
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$175063.47M
Annual income
$130,231,186,587.70
Full HYBT calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — HYBT vs ORCC

📍 HYBT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHYBTORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HYBT + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HYBT pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HYBT
Annual income on $10K today (after 15% tax)
$48,571.43/yr
After 10yr DRIP, annual income (after tax)
$110,696,508,599.55/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, HYBT beats the other by $110,696,508,598.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HYBT + ORCC for your $10,000?

HYBT: 50%ORCC: 50%
100% ORCC50/50100% HYBT
Portfolio after 10yr
$87531.74M
Annual income
$65,115,593,294.37/yr
Blended yield
74.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

HYBT
No analyst data
Altman Z
10.0
Piotroski
4/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HYBT buys
0
ORCC buys
0
No recent congressional trades found for HYBT or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHYBTORCC
Forward yield571.43%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$175063.47M$21.4K
Annual income after 10y$130,231,186,587.70$1.04
Total dividends collected$171282.55M$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: HYBT vs ORCC ($10,000, DRIP)

YearHYBT PortfolioHYBT Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$67,843$57,142.86$11,190$489.61+$56.7KHYBT
2$434,904$362,311.65$12,229$256.01+$422.7KHYBT
3$2,635,984$2,170,637.54$13,216$130.74+$2.62MHYBT
4$15,116,208$12,295,705.05$14,207$66.02+$15.10MHYBT
5$82,071,959$65,897,616.56$15,234$33.17+$82.06MHYBT
6$422,195,127$334,378,130.08$16,317$16.62+$422.18MHYBT
7$2,059,328,440$1,607,579,654.60$17,468$8.32+$2059.31MHYBT
8$9,531,745,742$7,328,264,311.53$18,695$4.16+$9531.73MHYBT
9$41,899,326,827$31,700,358,882.77$20,006$2.08+$41899.31MHYBT
10$175,063,466,293$130,231,186,587.70$21,407$1.04+$175063.44MHYBT

HYBT vs ORCC: Complete Analysis 2026

HYBTStock

Heyu Biological Technology Corporation, together with its subsidiaries, engages in research, development, and manufacturing of healthcare equipment. It is currently focused on developing Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber. The company was formerly known as Pacific WebWorks, Inc. and changed its name to Heyu Biological Technology Corporation in June 2018. Heyu Biological Technology Corporation was incorporated in 1987 and is based in Xiamen, the People's Republic of China.

Full HYBT Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this HYBT vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HYBT vs SCHDHYBT vs JEPIHYBT vs OHYBT vs KOHYBT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.